Molecule is a technology company.
Molecule has raised $21.0M across 2 funding rounds.
Molecule has raised $21.0M in total across 2 funding rounds.
Molecule (molecule.io) is a Houston-based technology company providing cloud-native ETRM/CTRM software for energy and commodity trading risk management. It builds a centralized system for accurate, near real-time position, exposure, and P&L reporting across 50+ commodities, handling 25,000+ physical and financial products daily—representing nearly $100bn in value. Serving hedge funds to Fortune 100 companies in renewables, power, gas, crude, and more, Molecule solves inefficiencies like spreadsheet chaos and slow reconciliation by offering integrations with exchanges, clearing firms, ERPs, Excel, and Power BI, plus enterprise security via SOC 1 Type 2 and SOC 2 Type 2 certifications[1][3]. Recent growth includes a $12M Series A for global expansion and a Series B for power/renewables focus, with wins like Nuveen's renewables trading adoption in Europe[1].
(Note: A separate entity at molecule.xyz operates a Web3 platform for biopharma IP fractionalization, but the query aligns with the prominent ETRM player at molecule.io based on funding and scale[2].)
Molecule emerged from the need to modernize energy trading operations, headquartered in Houston—the energy hub. While exact founding details and founders are not specified in available sources, the company quickly gained traction with its cloud-native approach, raising a $12M Series A to bring advanced ETRM/CTRM to global markets from existing and new investors[1][3]. Pivotal moments include launching Hive, a renewables-specific risk management product, completing SOC certifications for trust, and securing Series B funding to fuel power/renewables growth and European expansion via clients like Nuveen[1]. This trajectory reflects evolution from core trading tools to handling complex, high-volume portfolios amid rising energy transition demands[1][3].
Molecule rides the energy transition wave, capitalizing on renewables/power trading complexity amid global decarbonization—where portfolios demand handling larger datasets and volatile markets[1][3]. Timing aligns with surging commodity volumes ($100bn daily across users) and Europe's green push, as seen in Nuveen's adoption[1]. Market forces like cloud adoption in trading, real-time analytics needs, and regulatory scrutiny on risk favor its modern stack over outdated on-premise rivals[3]. It influences the ecosystem by enabling faster scaling for traders—from startups to giants—accelerating renewables deployment and financialization of green energy[1].
Molecule's momentum positions it for dominance in cloud ETRM, with Series B fueling renewables/power expansion and global reach. Trends like AI-driven risk modeling, deeper Web3/commodity tokenization, and PtX/CCUS growth will shape its path, potentially integrating advanced forecasting or blockchain for settlements. Influence may evolve toward ecosystem leader, powering $trillions in trades as energy markets digitize—building on its $100bn daily benchmark to redefine trading efficiency[1][3].
Molecule has raised $21.0M in total across 2 funding rounds.
Molecule's investors include Canaan Partners, Curie.Bio, Delta Blockchain Fund, Founder Collective, Insight Partners, Operator Partners, Shine Capital, The Finger Group, Scott Belsky, William Hockey, 42CAP, Acequia Capital.
Molecule has raised $21.0M across 2 funding rounds. Most recently, it raised $8.0M Seed in November 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2022 | $8.0M Seed | Canaan Partners, Curie.Bio, Delta Blockchain Fund, Founder Collective, Insight Partners, Operator Partners, Shine Capital, The Finger Group, Scott Belsky, William Hockey | |
| Jun 1, 2022 | $13.0M Seed | 42CAP, Acequia Capital, Amino Collective, Atria Ventures, Basecamp Fund, Delta Blockchain Fund, Entrepreneur First, Faber, Sequoia Capital, Spacecadet Ventures, Bradley Horowitz, Charlie Songhurst, Juney Ham, Moshe Lifschitz, Ryan Shea, Will Prendergast |